Arctic Bioscience AS Sustainability Reports
Arctic Bioscience AS is a marine biotechnology company that develops and commercializes pharmaceutical products and nutraceutical ingredients derived from bioactive marine compounds. Its primary clinical focus is developing HRO350, an oral drug candidate for the treatment of mild-to-moderate psoriasis, alongside marketing omega-3 dietary supplements under the Romega brand.
Sector: Manufacturing
Country: Norway
Exchange: Oslo Børs
LEI: 549300Z2HW6I989Q2C78
FIGI: BBG00Z9066T1
5 reports from 2021 to 2025
